S100A8 and Hypercholesterolemia: Recently, the study by Ninomiya et al. revealed that CagA may participate in development of atherosclerosis by inhibition of LDL uptake into cells by binding to LDL receptor, which may cause acceleration of LDL in plasma and thus hypercholesterolaemia [47].